Skip to content
DataLookout
Menu

NCT07468695

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 7 months later, primary endpoint(s) modified.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Dec 31, 2027 to May 31, 2028
  2. Notable Recruitment opened Show 4 more changesShow less
    • Primary endpoint(s) modified
    • Start date changed from estimate of Oct 15, 2026 to Oct 12, 2026
    • Site details revised
    • Study title shortened, about 2 words
  3. Notable Primary and study completion pushed from May 31, 2027 to Dec 31, 2027
    • Eligibility criteria expanded, about 16 words
    • Collaborators: details revised at 1 of 6 entries
  4. Notable Start date: Mar 2026 to Oct 15, 2026v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

HPV positive
Timeframe: From enrollment to follow up at 6 months

Arms and interventions

Group 1 (TA with 1 probe)Experimental

Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 1 probe at month 0.

Group 2 (TA with 2 probes)Experimental

Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 2 probes at month 0.

Procedures: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes

Sites

1 site in 1 country

  • Coptic Hope CenterNairobi, Kenya